NR1D2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.01123578797069E-13 |
Normal-vs-Stage2 |
1.077490E-03 |
Normal-vs-Stage3 |
1.62447832963153E-12 |
Normal-vs-Stage4 |
1.62725388719309E-12 |
Stage1-vs-Stage2 |
7.714000E-01 |
Stage1-vs-Stage3 |
2.58549999965219E-07 |
Stage1-vs-Stage4 |
1.396620E-04 |
Stage2-vs-Stage3 |
4.578300E-02 |
Stage2-vs-Stage4 |
6.058400E-02 |
Stage3-vs-Stage4 |
8.785200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.6242562850266E-12 |
Normal-vs-AfricanAmerican |
2.40419995023444E-09 |
Normal-vs-Asian |
1.692610E-01 |
Caucasian-vs-AfricanAmerican |
8.069200E-01 |
Caucasian-vs-Asian |
1.092390E-01 |
AfricanAmerican-vs-Asian |
9.547700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.03028696685215E-13 |
Normal-vs-Female |
1.07025499573865E-13 |
Male-vs-Female |
1.833560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.78157999999318E-05 |
Normal-vs-Age(41-60Yrs) |
1.13559994741053E-09 |
Normal-vs-Age(61-80Yrs) |
1.63846713974181E-12 |
Normal-vs-Age(81-100Yrs) |
6.18494144788428E-12 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.727400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.320400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.322560E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.635800E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.260000E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.480000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.682700E-03 |
Normal-vs-Grade 2 |
1.90060001070691E-09 |
Normal-vs-Grade 3 |
1.6494583476856E-12 |
Normal-vs-Grade 4 |
1.11022302462516E-16 |
Grade 1-vs-Grade 2 |
2.212600E-01 |
Grade 1-vs-Grade 3 |
2.148100E-02 |
Grade 1-vs-Grade 4 |
1.059540E-03 |
Grade 2-vs-Grade 3 |
4.538700E-03 |
Grade 2-vs-Grade 4 |
3.63749999999774E-05 |
Grade 3-vs-Grade 4 |
3.804200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
9.92870230476228E-11 |
Normal-vs-ccB subtype |
8.3171247666769E-12 |
ccA subtype-vs-ccB subtype |
6.261000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.28559401907569E-12 |
Normal-vs-N1 |
5.80779999981296E-07 |
N0-vs-N1 |
5.322000E-02 |
|
|